Mostrar el registro sencillo del ítem
| dc.contributor.author | Sánchez-Migallón, María-del-Cielo | |
| dc.contributor.author | Di-Pierdomenico, Johnny | |
| dc.contributor.author | Gallego-Ortega, Alejandro | |
| dc.contributor.author | García-Ayuso, Diego | |
| dc.contributor.author | Vidal-Sanz, Manuel | |
| dc.contributor.author | Agudo-Barriuso, Marta | |
| dc.contributor.author | Valiente-Soriano, Francisco-Javier | |
| dc.date.accessioned | 2025-11-26T11:46:47Z | |
| dc.date.available | 2025-11-26T11:46:47Z | |
| dc.date.issued | 2024-10 | |
| dc.identifier.citation | Minocycline Administration Does Not Have an Effect on Retinal Ganglion Cell Survival in a Murine Model of Ocular Hypertension. Aging dis [Internet]. 2024 [citado 25 de noviembre de 2025]; Disponible en: https://www.aginganddisease.org/EN/10.14336/AD.2024.0224 | |
| dc.identifier.issn | 2152-5250 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/22684 | |
| dc.description.abstract | This study aims to investigate two key aspects in a mouse model of ocular hypertension (OHT): first, the time course of retinal ganglion cell (RGC) death and the parallel activation of caspase-3 (a-Casp3+ cells) to narrow the therapeutic window; and second, the effect of caspase-3 and microglia inhibition by minocycline on RGC rescue in this model. RGC loss after OHT induction was significant at day 7 and progressed to 30 days. However, anatomical RGC death was preceded by significant Casp3 activation on day 3. Microglial inhibition by minocycline did not alter the course of OHT or rescue RGCs but resulted in a decrease in a-Casp3+ cells and phagocytic and total microglia. Therefore, RGC death commitment occurs earlier than their loss of Brn3a expression, microglial cells do not exacerbate RGC loss, and while this death is primarily apoptotic, apoptosis inhibition does not rescue RGCs, suggesting that alternative death pathways play a role in glaucomatous injury. | |
| dc.language.iso | eng | |
| dc.publisher | INT SOC AGING & DISEASE | |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0 | * |
| dc.subject.mesh | Animals | |
| dc.subject.mesh | Retinal Ganglion Cells/drug effects/pathology/metabolism | |
| dc.subject.mesh | Minocycline/pharmacology/therapeutic use/administration & dosage | |
| dc.subject.mesh | Ocular Hypertension/drug therapy/pathology | |
| dc.subject.mesh | Mice | |
| dc.subject.mesh | Disease Models, Animal | |
| dc.subject.mesh | Cell Survival/drug effects | |
| dc.subject.mesh | Caspase 3/metabolism | |
| dc.subject.mesh | Apoptosis/drug effects | |
| dc.subject.mesh | Microglia/drug effects/metabolism | |
| dc.subject.mesh | Mice, Inbred C57BL | |
| dc.title | Minocycline Administration Does Not Have an Effect on Retinal Ganglion Cell Survival in a Murine Model of Ocular Hypertension | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 38502581 | |
| dc.relation.publisherversion | https://www.aginganddisease.org/EN/10.14336/AD.2024.0224 | |
| dc.identifier.doi | 10.14336/AD.2024.0224 | |
| dc.journal.title | Aging and Disease |